Publicacións en colaboración con investigadores/as de University of Groningen (5)

2023

  1. FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective

    European Journal of Nuclear Medicine and Molecular Imaging

2022

  1. Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET

    Journal of Controlled Release, Vol. 347, pp. 500-507

2021

  1. Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 13, pp. 4307-4317

  2. In Vivo Induction of P-Glycoprotein Function can be Measured with [18F]MC225 and PET

    Molecular Pharmaceutics, Vol. 18, Núm. 8, pp. 3073-3085

2020

  1. Test-Retest Repeatability of [18F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function

    ACS Chemical Neuroscience, Vol. 11, Núm. 4, pp. 648-658